Insider · CIK 0001111408

PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

Reports to the SEC for 6 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001111408

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-05-11	MAP Pharmaceuticals, Inc.J Other	10% Owner	JOther	−1M sh	—	—	1,826,169
2010-02-11	MAP Pharmaceuticals, Inc.J Other	10% Owner	JOther	−1.25M sh	—	—	2,826,169
2007-07-10	BIOENVISION INCJ Other	10% Owner	JOther	−3.38M sh	$5.60	−$18.9M	0
2007-07-10	BIOENVISION INCSeries A Convertible Preferred StockJ Other	10% Owner	JOther	−2.25M sh	$3.00	−$6.75M	0
2005-12-14	Adams Respiratory Therapeutics, Inc.S Sale	10% Owner	SSale	−1.72M sh	$43.75	−$75.1M	3,372,918
2005-07-26	Adams Respiratory Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.62M sh	—	—	5,177,604
2005-07-26	Adams Respiratory Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.52M sh	—	—	6,697,376
2005-07-26	Adams Respiratory Therapeutics, Inc.S Sale	10% Owner	SSale	−1.61M sh	$15.81	−$25.4M	5,088,376
2005-07-26	Adams Respiratory Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−3.62M sh	—	—	0
2005-07-26	Adams Respiratory Therapeutics, Inc.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.52M sh	—	—	0
2005-06-30	AUXILIUM PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+612K sh	$4.90	+$3M	3,877,403
2005-06-30	AUXILIUM PHARMACEUTICALS INCWarrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+153K sh	—	—	153,022
2005-02-15	BARRIER THERAPEUTICS INCS Sale	See footnote (2)	SSale	−430K sh	$19.50	−$8.39M	2,324,734
2004-12-13	BIOENVISION INCC Conversion	10% Owner	CConversion	+1.5M sh	—	—	1,875,044
2004-12-13	BIOENVISION INCJ Other	10% Owner	JOther	−1.5M sh	—	—	375,044
2004-12-13	BIOENVISION INCSeries A Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−750K sh	—	—	2,250,000
2004-12-13	BIOENVISION INCC Conversion	10% Owner	CConversion	+1.5M sh	—	—	1,875,044
2004-12-13	BIOENVISION INCJ Other	10% Owner	JOther	−1.5M sh	—	—	375,044
2004-12-13	BIOENVISION INCSeries A Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−750K sh	—	—	2,250,000
2004-04-28	BARRIER THERAPEUTICS INCC Conversion	See footnote (2)	CConversion	+2.75M sh	—	—	2,754,738
2004-04-28	BARRIER THERAPEUTICS INCSeries B Convertible Preferred StockC Conversion	See footnote (2)	CConversion	−4.67M sh	—	—	0
2004-04-28	BARRIER THERAPEUTICS INCSeries C Convertible Preferred StockC Conversion	See footnote (2)	CConversion	−843K sh	—	—	0
2003-12-31	Vaneltix Pharma, Inc.P Purchase	10% Owner	PPurchase	+488K sh	$2.05	+$1M	1,892,334
2003-12-31	Vaneltix Pharma, Inc.Common Stock Purchase Warrant (right to buy)P Purchase	10% Owner	PPurchase	+195K sh	—	—	195,122

Recent filings

Accepted (ET)
May 134
MAP Pharmaceuticals, Inc.0000950142-10-000816
SEC(opens sec.gov)
Feb 164
MAP Pharmaceuticals, Inc.0000950142-10-000276
SEC(opens sec.gov)
Jul 124
BIOENVISION INC0000950142-07-001594
SEC(opens sec.gov)
Dec 154
PERSEUSPUR LLC0000950142-05-003218
SEC(opens sec.gov)
Jul 284
Adams Respiratory Therapeutics, Inc.0000950142-05-002163
SEC(opens sec.gov)
Jul 54
PERSEUS SOROS PARTNERS LLC0000950142-05-001941
SEC(opens sec.gov)
Feb 174
BARRIER THERAPEUTICS INC0000950142-05-000473
SEC(opens sec.gov)
Dec 164/A
BIOENVISION INC0000950142-04-004316
SEC(opens sec.gov)
Dec 164
SFM PARTICIPATION LP0000950142-04-004310
SEC(opens sec.gov)
Apr 304
BARRIER THERAPEUTICS INC0000950142-04-001468
SEC(opens sec.gov)

Companies

Address

888 SEVENTH AVE 30TH FLR

NEW YORK, NY, 10106